SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Adjustments to Additional Paid in Capital, Other
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) reported Adjustments to Additional Paid in Capital, Other of $147 for the 3-month period ending 2024-03-31, per its 10-Q/A filed 2024-09-04.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2024-09-04
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. adjustments to additional paid in capital, other for the quarter ending 2024-03-31 was $147.00.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. adjustments to additional paid in capital, other for the quarter ending 2023-12-31 was $1.00.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month | Adjustments to Additional Paid in Capital, Other 6 month | Adjustments to Additional Paid in Capital, Other 9 month | Adjustments to Additional Paid in Capital, Other 12 month |
|---|---|---|---|---|
| 2024-03-31 | $147.00 10-Q/A · filed 2024-09-04 | $148.00 derived: sum of 2 quarters · filed 2024-09-04 | ||
| 2023-12-31 | $1.00 derived: 10-Q/A 12 month − 10-K/A 9 month · filed 2024-09-04 | $141.00 10-Q/A · filed 2024-09-04 | ||
| 2023-09-30 | $140.00 10-K/A · filed 2024-09-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |